A inmigrantes con problemas de salud se les podría negar la visa para entrar al país, por nueva directiva del gobierno de Trump

Los extranjeros que solicitan visas para vivir en Estados Unidos podrían ser rechazados si tienen ciertas afecciones médicas, como obesidad o diabetes, según una directiva emitida el jueves 6 de noviembre por la administración Trump. Esta directiva, incluida en un cable enviado por el Departamento de Estado a funcionarios de embajadas y consulados —y revisada…

Read More

How the Right AI Can Improve Health Risk Assessments

Healthcare needs a better way to collect information from all sources, organize it, summarize it and present it to providers in a way that lets them deliver the necessary treatment, confident that the material is sound and verifiable. The post How the Right AI Can Improve Health Risk Assessments appeared first on MedCity News.

Read More

AI Can Help Better Manage Polypharmacy Patients, Study Shows

New research was published this week analyzing how AI can be used to better manage medications for senior patients who use multiple medications simultaneously. It analyzed FeelBetter’s AI platform, which pinpoints patients at high risk of deterioration and preventable hospitalization due to suboptimal medication management. The post AI Can Help Better Manage Polypharmacy Patients, Study…

Read More

Nursing Homes and the AMA, Once Medicaid Defenders, Hang Back as GOP Mulls Big Cuts

When congressional Republicans in 2017 pushed to repeal the Affordable Care Act and slash Medicaid, dozens of physician groups, patient advocates, hospitals, and others rallied to defend the law and the safety-net program. Eight years later, two industry groups have been notably restrained as GOP lawmakers consider sweeping new Medicaid cuts: the American Medical Association…

Read More

Impact of financial incentives on the value of the marginal drug

From an interesting review paper in the Journal of Economic Perspectives by Craig Garthwaite: Although research and development investments clearly respond to market opportunities, the exact benefits created by these incremental investments remain unclear. This is largely because the exact marginal products developed in response to these incentives are elusive to identify. Certainly, the amount…

Read More